نتایج جستجو برای: omv

تعداد نتایج: 291  

Journal: :Infection and immunity 1999
F Oftung L M Naess L M Wetzler G E Korsvold A Aase E A Høiby R Dalseg J Holst T E Michaelsen B Haneberg

We have studied the ability of the Norwegian group B meningococcal outer membrane vesicle (OMV) vaccine, when administered intranasally without adjuvant, to induce T-cell responses in humans. A group of 12 vaccinees was immunized with four doses of OMVs (250 micrograms of protein/dose) at weekly intervals, and a single booster dose was given 5 months later. In vitro T-cell proliferation in resp...

Journal: :Journal of bacteriology 2012
Satoshi Shibata Karen L Visick

Robust biofilm formation by Vibrio fischeri depends upon activation of the symbiosis polysaccharide (syp) locus, which is achieved by overexpressing the RscS sensor kinase (RscS(+)). Other than the Syp polysaccharide, however, little is known about V. fischeri biofilm matrix components. In other bacteria, biofilms contain polysaccharides, secreted proteins, and outer membrane vesicles (OMVs). H...

2015
Su Hyuk Ko Jong Ik Jeon Young-Jeon Kim Ho Joo Yoon Hyeyoung Kim Nayoung Kim Joo Sung Kim Jung Mogg Kim

Eosinophil cationic protein (ECP), a cytotoxic protein contained in eosinophils granules, can contribute to various inflammatory responses. Although Helicobacter pylori infection increases infiltration of eosinophils, the mechanisms of eosinophil degranulation by H. pylori infection are largely unknown. The goal of this study was to investigate the role of H. pylori outer membrane vesicles (OMV...

2016
Sandro Roier Franz G. Zingl Fatih Cakar Stefan Schild

Outer membrane vesicle (OMV) release by Gram-negative bacteria has been observed and studied for decades. First considered as a by-product of cell lysis, it soon became evident that OMVs are actively secreted from the outer membrane (OM) of Gram-negative bacteria. Accordingly, these small particles (~ 10-300 nm in diameter) consist mainly of OM components like phospholipids (PLs), OM proteins, ...

Azam Bolhassani, Fateme Asgar Halvaee, Mehdi Mahdavi, Mohammad Mehdi Aslani, Mohammad Reza Aghasadeghi, Seyed Davar Siadat, Seyed Mehdi Sadat, Seyed Mohammad Mahdi Ghahari, Soheila Hekmat,

Background: A licensed vaccine against hepatitis C virus (HCV) has not become available to date. The stability and antigenicity of a targeted synthesized recombinant fusion protein consisting of a truncated core and NS3 (rC/N) of HCV had been predicted. Although safe antigens, recombinant proteins are not efficacious vaccines without adjuvants. The present study evaluated the immunogenicity of ...

Objective(s): The porins A and B and also outer membrane vesicles (OMVs) of Neisseria meningitidis are used for vaccine purposes. In the present study, we aimed to design a new vaccine candidate based on a fusion of PorA of serogroups A and B of N. meningitidis admixed with OMV and evaluate it in an animal model.Materials and Methods: Af...

Journal: :The Japanese journal of veterinary research 1991
D F Guo H Kodama M Onuma T Kimura M Yoshimizu

Seven strains of Oncorhynchus masou virus (OMV) genomes were analyzed with the restriction endonucleases BamHI, EcoRI, HindIII and SmaI. The restriction patterns of OMV strain DNAs were divided into four groups. Restriction profiles of high passage strains (00-7812, 65th passage, and H-83, 60th passage) were different from those of low passage strains (00-7812, 8th passage, and H-83, 6th passag...

Journal: :Microbiology and immunology 1988
T Kimura T Nishizawa M Yoshimizu E De Clercq

The highly potent and selective anti-herpesvirus agent, (E)-5-(2-bromovinyl)-2'deoxyuridine (BVdU), was examined for its inhibitory effect on the salmonid herpesviruses Oncorhynchus masou virus (OMV) and Herpesvirus salmonis (H. salmonis). Minimum inhibitory concentrations (MIC) of BVdU for OMV and H. salmonis were 1.25 and 3.0 micrograms/ml, respectively; these values were equal to or higher t...

Journal: :Infection and immunity 2006
Jamie Findlow Stephen Taylor Audun Aase Rachel Horton Robert Heyderman Jo Southern Nick Andrews Rita Barchha Ewan Harrison Ann Lowe Emma Boxer Charlotte Heaton Paul Balmer Ed Kaczmarski Philipp Oster Andrew Gorringe Ray Borrow Elizabeth Miller

The prediction of efficacy of Neisseria meningitidis serogroup B (MenB) vaccines is currently hindered due to the lack of an appropriate correlate of protection. For outer membrane vesicle (OMV) vaccines, immunogenicity has primarily been determined by the serum bactericidal antibody (SBA) assay and OMV enzyme-linked immunosorbent assay (ELISA). However, the opsonophagocytic assay (OPA), surfac...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید